Patient-Reported Burden of Illness and Unmet Needs in <i>Demodex</i> blepharitis. [PDF]
Gupta PK +7 more
europepmc +1 more source
Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis. [PDF]
Davey PG +7 more
europepmc +1 more source
A Systematic Review and Meta-Analysis of the Safety and Efficacy of 0.25% Lotilaner Ophthalmic Solution in the Treatment of Demodex Blepharitis. [PDF]
Awan B +6 more
europepmc +1 more source
The <i>Demodex</i> Expert Panel on Treatment and Eyelid Health (DEPTH) Consensus Regarding the Preferred Treatment for <i>Demodex</i> Blepharitis. [PDF]
Donnenfeld E +14 more
europepmc +1 more source
Multidisciplinary perspectives in Demodex blepharitis: A new view of treatment from clinical, payer, and patient perspectives. [PDF]
Page MR.
europepmc +1 more source
Demodex blepharitis: clinical perspectives. [PDF]
Fromstein SR +3 more
europepmc +1 more source
Blepharitis driven by microbiome dysbiosis and <i>Demodex</i> infestation: possible pathogenic mechanisms. [PDF]
Zhu M +6 more
europepmc +1 more source
The effect of Demodex-associated Bacillus oleronius proteins and hyperosmolarity on a human conjunctival epithelial cell line. [PDF]
Sharma N, Martin E, Pearce EI, Hagan S.
europepmc +1 more source
Information Entropy-Based Framework for Quantifying Curve Tortuosity in Meibomian Glands Uneven Atrophy. [PDF]
Wang K +7 more
europepmc +1 more source
Clinical characteristics and preliminary retrospective evidence of adjunctive efficacy of intense pulsed light therapy for Demodex-associated blepharokeratoconjunctivitis: a single-center study. [PDF]
Yang S +5 more
europepmc +1 more source

